19-42226405-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000301215.8(ZNF526):āc.2002G>Cā(p.Ala668Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,614,074 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000301215.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF526 | NM_133444.3 | c.2002G>C | p.Ala668Pro | missense_variant | 3/3 | ENST00000301215.8 | NP_597701.1 | |
ZNF526 | NM_001314033.3 | c.2002G>C | p.Ala668Pro | missense_variant | 3/3 | NP_001300962.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF526 | ENST00000301215.8 | c.2002G>C | p.Ala668Pro | missense_variant | 3/3 | 1 | NM_133444.3 | ENSP00000301215 | P1 | |
ZNF526 | ENST00000710326.1 | c.2002G>C | p.Ala668Pro | missense_variant | 3/3 | ENSP00000518206 | P1 | |||
GSK3A | ENST00000677025.1 | c.111C>G | p.Gly37= | synonymous_variant | 2/2 | ENSP00000503204 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249108Hom.: 1 AF XY: 0.0000222 AC XY: 3AN XY: 134858
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461866Hom.: 2 Cov.: 35 AF XY: 0.0000385 AC XY: 28AN XY: 727236
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 08, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.2002G>C (p.A668P) alteration is located in exon 3 (coding exon 1) of the ZNF526 gene. This alteration results from a G to C substitution at nucleotide position 2002, causing the alanine (A) at amino acid position 668 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at